Ardent Health (ARDT) Gains from Investment Securities (2023 - 2026)

Ardent Health has reported Gains from Investment Securities for 4 years, with the latest figure at -$187000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 187.38% year-over-year to -$187000.0; the trailing twelve-month figure through Mar 2026 stood at $36.1 million (down 13.65% YoY), and the FY2025 full-year result was $36.5 million, down 12.24% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$187000.0, down from $36.4 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $40.9 million in Q4 2024, with the low at -$236000.0 in Q3 2023.
• Average Gains from Investment Securities over 4 years is $9.6 million, with a median of $132000.0 recorded in 2025.
• Year-over-year, Gains from Investment Securities soared 437.29% in 2024 and slumped 187.38% in 2026.
• Tracing ARDT's Gains from Investment Securities over 4 years: stood at $18.1 million in 2023, then surged by 125.59% to $40.9 million in 2024, then fell by 10.88% to $36.4 million in 2025, then slumped by 100.51% to -$187000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$187000.0 (Q1 2026), $36.4 million (Q4 2025), and -$172000.0 (Q3 2025), per Business Quant data.

Peer Comparison